This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibbs Mavacamten StudyBristol Myers Squibb application for Opdivo Plus Yervoy for MSI-H/ dMMR colorectal cancer accepted...
Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector VersionSanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma
Govt Panel Directs Serum Institute of India to Add Guillain-Barre Syndrome Warning as Rare Side Effect of Covishield VaccineGovt Panel Directs Serum Institute of India to Add Guillain-Barre Syndrome Warning as Rare Side...
Healthtech Startup CURAPOD Raises Rs 20 Cr to Scale Wearable Pain Management TechnologyHealthcare recruitment platform Jobizo raises USD 1.4 million in pre-Series A funding
Emcure Pharma Gets CDSCO Panel Nod to Conduct Phase IV Trial on Drospirenone TabletsEmcure Pharma Pune facility gets 2 USFDA observations
Dr ReddyUSFDA issues EIR for Dr Reddy's Labs Hyderabad facility
Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur UnitCaplin Steriles gets USFDA nod for Eye Drop for reduction of elevated intraocular pressure
Marksans Pharma UK arm Relonchem gets marketing nod for high BP drugMarksans Pharma UK arm gets marketing nod for Ibuprofen, Paracetamol Film-coated Tablets
Gland Pharma Pashamylaram facility receives GMP compliance certificate from Danish Medicines AgencyGland Pharma gets 3 USFDA observations for Visakhapatnam facility
Cadila Pharma unveils advanced pharmaceutical warehouseCadila Pharma unveils advanced pharmaceutical warehouse
CDSCO Panel Approves BE Study for Alkems Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III PlanAlkem Laboratories Gets CDSCO Panel Nod To Study Semaglutide solution for injection
acquisitionGSK buys IDRx for up to USD 1.15 billion
X